These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 21257219
1. Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients. Katakami N, Kaneto H, Matsuhisa M, Shimomura I, Yamasaki Y. Diabetes Res Clin Pract; 2011 Apr; 92(1):e20-2. PubMed ID: 21257219 [Abstract] [Full Text] [Related]
2. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide. Massi-Benedetti M, Herz M, Pfeiffer C. Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982 [Abstract] [Full Text] [Related]
6. Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study. Khalangot M, Tronko M, Kravchenko V, Kovtun V. Diabetes Res Clin Pract; 2009 Dec; 86(3):247-53. PubMed ID: 19796836 [Abstract] [Full Text] [Related]
8. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447 [Abstract] [Full Text] [Related]
9. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits. Nieszner E, Posa I, Kocsis E, Pogátsa G, Préda I, Koltai MZ. Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084 [Abstract] [Full Text] [Related]
11. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy]. González-Ortiz M, Martínez-Abundis E, Grupo para el Tratamiento de la Diabetes Mellitus con Combinaciones. Rev Invest Clin; 2004 Aug; 56(3):327-33. PubMed ID: 15612515 [Abstract] [Full Text] [Related]
12. Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients. Abbink EJ, Pickkers P, Jansen van Rosendaal A, Lutterman JA, Tack CJ, Russel FG, Smits P. Diabet Med; 2002 Feb; 19(2):136-43. PubMed ID: 11874430 [Abstract] [Full Text] [Related]
15. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. Hedblad B, Zambanini A, Nilsson P, Janzon L, Berglund G. J Intern Med; 2007 Mar; 261(3):293-305. PubMed ID: 17305652 [Abstract] [Full Text] [Related]
16. Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. Spallarossa P, Schiavo M, Rossettin P, Cordone S, Olivotti L, Cordera R, Brunelli C. Diabetes Care; 2001 Apr; 24(4):738-42. PubMed ID: 11315840 [Abstract] [Full Text] [Related]
19. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial. Umpierrez G, Issa M, Vlajnic A. Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436 [Abstract] [Full Text] [Related]